Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)
China · Delayed Price · Currency is CNY 32.42
-0.98 (-2.93%)
Sep 1, 2026, 4:00 PM EDT
SHA:688197 Revenue
Shouyao Holdings (Beijing) Co., LTD. had revenue of 34.67M CNY in the twelve months ending June 30, 2026, up 1,518.45% year-over-year. In the year 2025, Shouyao Holdings (Beijing) Co., LTD. had annual revenue of 8.67M with 119.88% growth.
Revenue (ttm)
34.67M
Revenue Growth
+1,518.45%
P/S Ratio
139.08
Revenue / Employee
n/a
Employees
172
Market Cap
4.82B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.67M | 4.73M | 119.88% |
| Dec 31, 2024 | 3.94M | -1.29M | -24.61% |
| Dec 31, 2023 | 5.23M | 3.40M | 186.18% |
| Dec 31, 2022 | 1.83M | -11.21M | -85.98% |
| Dec 31, 2021 | 13.03M | 6.01M | 85.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Hvsen Biotechnology | 1.72B |
| Shenzhen Weiguang Biological Products | 1.20B |
| ChemPartner PharmaTech | 1.14B |
| Boji Medical Technology | 961.34M |
| R&G PharmaStudies | 939.31M |
| Beijing Konruns Pharmaceutical | 917.05M |
| Wuhan Keqian Biology Co.,Ltd | 836.28M |
| PharmaResources (Shanghai) | 700.02M |